Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rosina

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 13, 2005
CTLA4 gene polymorphism in Italian patients with colorectal adenoma and cancerE Solerio, G Tappero, L Iannace, et al.
Journal of Hepatology|January 1, 1986
Treatment of chronic delta hepatitis with alpha-2 recombinant interferonM Rizzetto, F Rosina, G Saracco, et al.
Hepatology (Baltimore, Md.)|December 1, 1993
Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2bG Saracco, F Rosina, M L Abate, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1987
Patterns of natural killer cell function activation in response to interferon in chronic HBsAG positive hepatitis: relationship with the state of viral infection and with the early clinical responseG C Actis, E Maran, F Bonino, et al.
Journal of Hepatology|November 1, 1990
Autoantibodies and response to alpha-interferon in patients with chronic viral hepatitisG Saracco, A Touscoz, M Durazzo, et al.
La Ricerca in Clinica E in Laboratorio|October 1, 1987
Interferon treatment of chronic hepatitis B surface antigen (HBsAg) carriers. A description of the activation profiles of natural killer cells obtained with different schedules of administration in three subsets of carriersG C Actis, E Maran, G Saracco, et al.
European Journal of Gastroenterology & Hepatology|June 1, 1997
Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniquesD S Bansi, M Bauducci, A Bergqvist, et al.
European Journal of Gastroenterology & Hepatology|September 1, 1995
Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease?F Castellino, F Rosina, D S Bansi, et al.
Scandinavian Journal of Gastroenterology|November 1, 2002
Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentationK M Boberg, A Bergquist, S Mitchell, et al.
Journal of Hepatology|January 1, 1990
A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitisG Saracco, F Rosina, M R Torrani Cerenzia, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 13, 2005
CTLA4 gene polymorphism in Italian patients with colorectal adenoma and cancerE Solerio, G Tappero, L Iannace, et al.
Journal of Hepatology|January 1, 1986
Treatment of chronic delta hepatitis with alpha-2 recombinant interferonM Rizzetto, F Rosina, G Saracco, et al.
Hepatology (Baltimore, Md.)|December 1, 1993
Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2bG Saracco, F Rosina, M L Abate, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1987
Patterns of natural killer cell function activation in response to interferon in chronic HBsAG positive hepatitis: relationship with the state of viral infection and with the early clinical responseG C Actis, E Maran, F Bonino, et al.
Journal of Hepatology|November 1, 1990
Autoantibodies and response to alpha-interferon in patients with chronic viral hepatitisG Saracco, A Touscoz, M Durazzo, et al.
La Ricerca in Clinica E in Laboratorio|October 1, 1987
Interferon treatment of chronic hepatitis B surface antigen (HBsAg) carriers. A description of the activation profiles of natural killer cells obtained with different schedules of administration in three subsets of carriersG C Actis, E Maran, G Saracco, et al.
European Journal of Gastroenterology & Hepatology|June 1, 1997
Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniquesD S Bansi, M Bauducci, A Bergqvist, et al.
European Journal of Gastroenterology & Hepatology|September 1, 1995
Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease?F Castellino, F Rosina, D S Bansi, et al.
Scandinavian Journal of Gastroenterology|November 1, 2002
Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentationK M Boberg, A Bergquist, S Mitchell, et al.
Journal of Hepatology|January 1, 1990
A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitisG Saracco, F Rosina, M R Torrani Cerenzia, et al.
Pageof 7